Khuram Chaudhry

An informatics-based data-led prioritization strategy to facilitate objective and equitable care for an ethnically diverse urban cohort of people with type 1 diabetes: A proof-of-concept study

Panagiotis Pavlou, Khuram Chaudhry, O French, Sarah Keane et autres

Background Ethnicity and socioeconomic factors contribute to higher morbidity and mortality in people with type 1 diabetes (pwT1D), partly due to reduced access to specialised care and technology. Objectively prioritising high-risk individuals in resource-limited settings is challenging. Data-led prioritisation (DLP) uses health …

gb, no (code pays fourni par la source)

Real‐world use of continuous glucose monitoring in people with type 2 diabetes and chronic kidney disease or on dialysis

Patrick McGown, Nikoleta Papanikolaou, Jasmine El‐Taraboulsi, Clemency Britton et autres

INTRODUCTION: Continuous glucose monitoring (CGM) has become the standard of care for people with type 1 diabetes (T1D) and some people with type 2 diabetes (T2D). However, there is a lack of data regarding CGM use in people with T2D and chronic …

gb (code pays fourni par la source)

Scoping Review—Diabetes Technology for Individuals on Kidney Replacement Therapy (Dialysis): Current Trends and Future Directions

Hellena Hailu Habte‐Asres, Joseph Ngmenesegre Suglo, Khuram Chaudhry, Angus Forbes et autres

Aim: This review aims to map the existing literature on the use of diabetes technology in people receiving dialysis, with a focus on utilization, accuracy, and effectiveness. Methods: A scoping review was conducted using the Joanna Briggs Institute methodology, with systematic searches …

gb (code pays fourni par la source)

Current management of chronic kidney disease in type‐2 diabetes—A tiered approach: An overview of the joint Association of British Clinical Diabetologists and UK Kidney Association ( ABCD ‐ UKKA ) guidelines

Indranil Dasgupta, Sagen Zac‐Varghese, Khuram Chaudhry, Kieran McCafferty et autres

A growing and significant number of people with diabetes develop chronic kidney disease (CKD). Diabetes-related CKD is a leading cause of end-stage kidney disease (ESKD) and people with diabetes and CKD have high morbidity and mortality, predominantly related to cardiovascular disease (CVD). …

gb (code pays fourni par la source)

Case series of using automated insulin delivery to improve glycaemic control in people with type 1 diabetes and end stage kidney disease on haemodialysis

Khuram Chaudhry, Rebecca Hyslop, Thomas Johnston, Siobhan Pender et autres

Automated insulin delivery (AID) in people with type 1 diabetes (pwT1D) and end-stage kidney disease (ESKD) on haemodialysis (HD) has not been reported previously. We describe practical considerations and our findings in four pwT1D on HD for ESKD where AID was safely …

gb (code pays fourni par la source)

Chronic kidney disease in type 2 diabetes: The size of the problem, addressing residual renal risk and what we have learned from the CREDENCE trial

Khuram Chaudhry, Janaka Karalliedde

Chronic kidney disease (CKD) associated with type 2 diabetes (T2DM) is a global challenge; progression to end-stage kidney disease (ESKD) and increased risk of cardiovascular disease (CVD) associated with advancing nephropathy are a significant source of morbidity, mortality, and healthcare expenditure. Until …

gb (code pays fourni par la source)

Author response for "Chronic kidney disease in type 2 diabetes: The size of the problem, addressing residual renal risk and what we have learned from the CREDENCE trial"

Khuram Chaudhry, Janaka Karalliedde